As the poultry industry increasingly uses more direct-fed microbials, the question arises as to why do they use them or more importantly, what does the industry expect to obtain from their use? We will review the developmental process used to create a product to offer the industry its desired need and how products vary by design. We will compare and contrast both microbial content and usage rates.

What you will learn:
• Process used to develop a best-in-class DFM
• Focused effects from differing microbes
• How DFM’s differ by design
• Role of CFU counts versus feeding rates

Dr. Bruce Johnson is Corporate Vice President, Global Business Development for Phibro Animal Health Corporation. In this capacity, his leadership has focused on creating an innovative, scientifically focused portfolio of nutritional compounds and products. His expansion on microbial products and usage continues to increase and led to the acquisition of Osprey Biotechnics as part of the PAHC family. Dr. Johnson holds a PhD in Animal Nutrition and Biochemistry and has strong, global experience driving product development research and customer interaction.